Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

What is Target Discovery?

Target discovery helps identifying drug targets, molecules or molecular interactions at a critical point in a disease-causing pathway that are predicted to being amenable to therapeutic manipulation. The centre aims to link recent advances in genetics, genomics, cell and chemical biology for improved drug target discovery. A more specific focus for refining and validating such targets will provide a better link between traditional "open ended" academic processes to biomedical research and the need of the pharmaceutical industry for accurately defined targets to accelerate drug development.

Latest News

Nobel Prize for Medicine awarded to NDM Professor Sir Peter Ratcliffe

Peter Ratcliffe, William Kaelin and Gregg Semenza share the 2019 Nobel Prize for or Physiology and Medicine. They discovered how cells sense and adapt to oxygen levels, findings that affect our day-to-day life from exercise, to being at high altitudes to our early development in the womb. Their work is leading to new treatments for anaemia and even cancer

Research identifies how the gut loses protective barrier function in IBD

A single-cell based study from Prof Alison Simmons Lab describes clonic epithelial cell diversity in health and inflammatory bowel disease (IBD).

Big Data Institute announces two new research alliances

The Big Data Institute (BDI) has recently announced new research alliances with Novartis and Sensyne Health.